In last trading session, Ventyx Biosciences Inc (NASDAQ:VTYX) saw 1.05 million shares changing hands with its beta currently measuring 0.94. Company’s recent per share price level of $2.4 trading at -$0.01 or -0.41% at ring of the bell on the day assigns it a market valuation of $170.79M. That closing price of VTYX’s stock is at a discount of -41.25% from its 52-week high price of $3.39 and is indicating a premium of 67.5% from its 52-week low price of $0.78.
For Ventyx Biosciences Inc (VTYX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.75. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Ventyx Biosciences Inc (NASDAQ:VTYX) trade information
Upright in the red during last session for losing -0.41%, in the last five days VTYX remained trading in the green while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $2.4 price level, adding 4.0% to its value on the day. Ventyx Biosciences Inc’s shares saw a change of -4.38% in year-to-date performance and have moved 9.09% in past 5-day. Ventyx Biosciences Inc (NASDAQ:VTYX) showed a performance of 42.01% in past 30-days.
Wall Street analysts have assigned a consensus price target of 45 to the stock, which implies a rise of 94.67% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 60. It follows that stock’s current price would drop -150.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -150.0% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -87.13% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 4.21% while estimates for its earnings growth in next 5 years are of 1.46%.
Ventyx Biosciences Inc (NASDAQ:VTYX)’s Major holders
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at VTYX for having 5.83 million shares of worth $13.47 million. And as of 2024-06-30, it was holding 8.2625 of the company’s outstanding shares.
The second largest institutional holder is CITADEL ADVISORS LLC, which was holding about 5.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.1616 of outstanding shares, having a total worth of $13.3 million.
